当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 利润表

海尔生物

(688139)

  

流通市值:124.07亿  总市值:124.07亿
流通股本:3.18亿   总股本:3.18亿

利润表

报告期2023-06-302023-03-312022-12-312022-09-30
公司类型通用通用通用通用
一、营业总收入1,270,455,870.9686,668,622.182,864,044,617.292,075,274,671.51
营业收入1,270,455,870.9686,668,622.182,864,044,617.292,075,274,671.51
二、营业总成本1,034,950,299.72557,268,271.772,293,396,024.591,641,257,015.03
营业成本613,796,745.2336,351,587.421,484,880,539.761,095,594,661.45
税金及附加11,684,386.055,968,665.0422,599,966.9416,160,969.24
销售费用168,807,126.280,360,225.34348,370,345.86238,609,885.42
管理费用93,716,330.7445,572,426.09165,354,502.35112,970,786.5
研发费用157,574,507.0980,011,141.6292,470,141.2211,246,026.69
财务费用-10,628,795.569,004,226.28-20,279,471.52-33,325,314.27
其中:利息费用1,877,762.2888,122.92,685,008.741,880,060.05
其中:利息收入14,578,931.766,774,013.320,299,595.4315,450,024.47
加:公允价值变动收益1,459,949.22319,226.22-7,007,496.25-6,299,452.72
加:投资收益58,134,146.0113,015,767.8574,721,447.9556,181,707.06
资产处置收益-2,062,769.54--312,748.52594,477.54
资产减值损失(新)-1,520,953.03545,754.01-5,410,210.13-2,223,189.11
信用减值损失(新)-431,240.0947,880.39-1,115,799.29805,423.21
其他收益20,940,129.358,013,605.5944,156,408.0631,382,446.02
营业利润平衡项目0000
四、营业利润312,024,833.1151,342,584.47675,680,194.52514,459,068.48
加:营业外收入1,309,461677,842.133,135,162.751,830,275.31
减:营业外支出6,069,189.7926,898.423,479,274.89192,046.76
利润总额平衡项目0000
五、利润总额307,265,104.31151,993,528.18675,336,082.38516,097,297.03
减:所得税费用23,053,475.2712,483,714.6763,362,053.4251,553,792.53
六、净利润284,211,629.04139,509,813.51611,974,028.96464,543,504.5
持续经营净利润284,211,629.04139,509,813.51611,974,028.96464,543,504.5
归属于母公司股东的净利润278,462,841.61137,535,031.82600,791,263.18461,446,373.79
少数股东损益5,748,787.431,974,781.6911,182,765.783,097,130.71
(一)基本每股收益0.880.431.891.46
(二)稀释每股收益0.880.431.891.46
八、其他综合收益-29,978,428.7398,055.44-30,441,133.612,214,447.36
归属于母公司股东的其他综合收益-29,978,428.7398,055.44-30,441,133.612,214,447.36
九、综合收益总额254,233,200.31139,607,868.95581,532,895.35466,757,951.86
归属于母公司股东的综合收益总额248,484,412.88137,633,087.26570,350,129.57463,660,821.15
归属于少数股东的综合收益总额5,748,787.431,974,781.6911,182,765.783,097,130.71
公告日期2023-08-302023-04-262023-03-292022-10-24
审计意见(境内)标准无保留意见
TOP↑